antipsychotics targets Dopamine D2 receptor
Evidence from:
primary |
all sources
Evidence (3 sources)
Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder.
(2024)
PMID:38637617
primary
gene-wise associations with DRD2 (antipsychotics)
confidence: 0.90
DRD2 (encoding a key target of antipsychotics)
confidence: 0.96
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression.
(2018)
PMID:29700475
cited
DRD2, a principal target of antipsychotics
confidence: 0.96